Literature DB >> 29730394

New insights into the epigenetics of osteoporosis.

Jean-Guillaume Letarouilly1, Odile Broux2, Aline Clabaut3.   

Abstract

Osteoporosis is characterized by reduced bone formation and accumulation of adipocytes in the bone marrow compartment. The decrease in bone mass results from an imbalance between osteoclast-mediated bone resorption and osteoblast-mediated bone formation. The deficiency of bone cells to replace the resorpted bone can be due to a preferential differentiation of bone marrow stromal cells into adipocytes at the expense of osteoblasts. Consequently, the processes that control the differentiation of osteoclasts, osteoblasts and adipocytes play a crucial role in bone metabolism. It is known that epigenetic mechanisms are critical regulator of the differentiation programs for cell fate and moreover are subject to changes during aging. Here, we summarize recent findings on the role of epigenetics in the modulation of mechanisms that may be associated with osteoporosis. In particular, we focus on disturbances in the bone remodeling process described in human studies that address the epigenetic regulation of the osteoblast/adipocyte balance.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adipocyte; Differentiation; Epigenetics; Human osteoporosis; Osteoblast; Osteoclast

Year:  2018        PMID: 29730394     DOI: 10.1016/j.ygeno.2018.05.001

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

Review 1.  Micro-RNA: A Future Approach to Personalized Diagnosis of Bone Diseases.

Authors:  Giovanni Lombardi; Edgard Delvin
Journal:  Calcif Tissue Int       Date:  2022-02-19       Impact factor: 4.333

2.  Deciphering the Underlying Mechanism of Eucommiae Cortex against Osteoporotic Fracture by Network Pharmacology.

Authors:  Yongming Shuai; Zhili Jiang; Qiuwen Yuan; Shuqiang Tu; Fanhui Zeng
Journal:  Evid Based Complement Alternat Med       Date:  2020-09-07       Impact factor: 2.629

Review 3.  The Spectrum of Fundamental Basic Science Discoveries Contributing to Organismal Aging.

Authors:  Joshua N Farr; Maria Almeida
Journal:  J Bone Miner Res       Date:  2018-08-13       Impact factor: 6.741

Review 4.  Recent advances in the epigenetics of bone metabolism.

Authors:  Yuexin Xu; Jing Ma; Guohua Xu; Duan Ma
Journal:  J Bone Miner Metab       Date:  2021-07-11       Impact factor: 2.626

5.  Deciphering the underlying mechanism of Xianlinggubao capsule against osteoporosis by network pharmacology.

Authors:  Hangsheng Bao; Huizhi Guo; Zongquan Feng; Xin Li
Journal:  BMC Complement Med Ther       Date:  2020-07-03

Review 6.  Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis.

Authors:  Babak Arjmand; Masoumeh Sarvari; Sepideh Alavi-Moghadam; Moloud Payab; Parisa Goodarzi; Kambiz Gilany; Neda Mehrdad; Bagher Larijani
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-03       Impact factor: 5.555

7.  The effects of vasoactive intestinal peptide on RANKL-induced osteoclast formation.

Authors:  Hongyi Qu; Yan Zhuang; Lin Zhu; Zuohui Zhao; Kelai Wang
Journal:  Ann Transl Med       Date:  2021-01

8.  Nrf2 epigenetic derepression induced by running exercise protects against osteoporosis.

Authors:  Xingren Chen; Xiaobo Zhu; Ai Wei; Fang Chen; Qi Gao; Ke Lu; Qing Jiang; Wangsen Cao
Journal:  Bone Res       Date:  2021-02-26       Impact factor: 13.567

9.  Polydatin improves osteogenic differentiation of human bone mesenchymal stem cells by stimulating TAZ expression via BMP2-Wnt/β-catenin signaling pathway.

Authors:  Ying-Shan Shen; Xiao-Jun Chen; Sha-Na Wuri; Fan Yang; Feng-Xiang Pang; Liang-Liang Xu; Wei He; Qiu-Shi Wei
Journal:  Stem Cell Res Ther       Date:  2020-05-27       Impact factor: 6.832

10.  Comparative transcriptome analysis identifies CARM1 and DNMT3A as genes associated with osteoporosis.

Authors:  Layla Panach; Clara Pertusa; Beatriz Martínez-Rojas; Álvaro Acebrón; Damián Mifsut; Juan J Tarín; Antonio Cano; Miguel Ángel García-Pérez
Journal:  Sci Rep       Date:  2020-10-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.